tenk.fyi

ZyVersa Therapeutics, Inc.

ZVSAOTC· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$9.4M

90.4% YoY

EPS

$-8.48

99.2% YoY

Cash

$1.5M

51.2% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro